Xenon Pharmaceuticals Announces Upcoming Investor Webinar with Leading Key Opinion Leaders to Discuss XEN1101 and Major Depressive Disorder
13 September 2023 - 6:30AM
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused
biopharmaceutical company, today announced that the company will
host an investor webinar with two leading key opinion leaders
(KOLs) focused on major depressive disorder.
Webinar: |
“XEN1101 and
the Major Depressive Disorder (MDD) Landscape: A Discussion with
KOLs” |
Date: |
Tuesday, September 19, 2023 |
Time: |
11:30 am – 1 pm ET Eastern Time (8:30 am – 11 am Pacific
Time) |
Link: |
Participants can register and access the webinar on the
Investors section of Xenon’s website. |
Format: |
Questions may be submitted (via chat function) during the live
webinar or submitted in advance via email. |
|
|
Speakers include:
- Sanjay J.
Mathew, MD, Marjorie Bintliff Johnson and Raleigh White Johnson,
Jr. Vice Chair for Research Professor of Psychiatry &
Behavioral Sciences Menninger Department of Psychiatry &
Behavioral Sciences at Baylor College of Medicine
- James W.
Murrough, MD, PhD, Professor of Psychiatry and Neuroscience
Director, Depression and Anxiety Center for Discovery and Treatment
Icahn School of Medicine at Mount Sinai
- Ian Mortimer,
President and CEO, Xenon Pharmaceuticals (moderator)
- Chris Kenney,
Chief Medical Officer, Xenon Pharmaceuticals
- Chris Von
Seggern, Chief Commercial Officer, Xenon Pharmaceuticals
A live webcast of the company presentation will
be available on the “Investors” section of Xenon's website and
posted for replay following the event. The above listed dates and
times are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a
clinical stage biopharmaceutical company committed to developing
innovative therapeutics to improve the lives of patients with
neurological disorders. We are advancing a novel product pipeline
of neurology therapies to address areas of high unmet medical need,
with a focus on epilepsy. For more information, please visit
www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered
trademarks or trademarks of Xenon Pharmaceuticals Inc. in various
jurisdictions. All other trademarks belong to their respective
owner.
Investor/Media Contact:Jodi RegtsXenon
Pharmaceuticals Inc.Phone: 604.484.3353Email:
investors@xenon-pharma.com
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Apr 2024 to May 2024
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From May 2023 to May 2024